Cargando…

Reinfection With SARS-CoV-2: Implications for Vaccines

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become pandemic and the duration of protective immunity to the virus is unknown. Cases of persons reinfected with the virus are being reported with increasing frequency. At present it is unclear how common reinfection wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Jeffrey I, Burbelo, Peter D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799323/ https://www.ncbi.nlm.nih.gov/pubmed/33338197 http://dx.doi.org/10.1093/cid/ciaa1866

Ejemplares similares

Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting
por: Abu-Raddad, Laith J, et al.
Publicado: (2020)

Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein
por: Kulkarni, Onkar, et al.
Publicado: (2021)

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
por: Teles, Mayan S, et al.
Publicado: (2022)

Viral Sequencing to Investigate Sources of SARS-CoV-2 Infection in US Healthcare Personnel
por: Braun, Katarina M, et al.
Publicado: (2021)

No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection
por: Laurenzi, Andrea, et al.
Publicado: (2021)

Comparison between the Sofia SARS Antigen FIA Test and the PCR Test in Detection of SARS-CoV-2 Infection
por: Černila, Manca, et al.
Publicado: (2022)

Is There an Association Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Streptococcus pneumoniae?
por: Howard, Leigh M
Publicado: (2020)

Social Distancing Measures: Evidence of Interruption of Seasonal Influenza Activity and Early Lessons of the SARS-CoV-2 Pandemic
por: Wiese, Andrew D, et al.
Publicado: (2020)

The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam
por: Thai, Pham Quang, et al.
Publicado: (2020)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
por: Wang, Kai, et al.
Publicado: (2020)

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
por: Swift, Melanie D, et al.
Publicado: (2021)

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
por: Lumley, Sheila F, et al.
Publicado: (2021)

Comparing Nasopharyngeal Swab and Early Morning Saliva for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Rao, Mohan, et al.
Publicado: (2020)

A Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prediction Model From Standard Laboratory Tests
por: Bayat, Vafa, et al.
Publicado: (2020)

Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model
por: Li, Can, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis
por: Thompson, Hayley A, et al.
Publicado: (2021)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Asymptomatic Infections in 2 Large Academic Health Systems in Wisconsin
por: Rivera, Frida, et al.
Publicado: (2020)

Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around
por: Kim, Arthur Y, et al.
Publicado: (2020)

Usability and Acceptability of Home-based Self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies for Population Surveillance
por: Atchison, Christina, et al.
Publicado: (2020)

Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
por: Pedraza, Alexandra, et al.
Publicado: (2022)

Diagnosing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium
por: Rowley, Anne H
Publicado: (2020)

Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic
por: Pirofski, Liise-anne
Publicado: (2021)

The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up
por: Ujjani, Chaitra S., et al.
Publicado: (2022)

Infant Outcomes Following Maternal Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): First Report From the Pregnancy Coronavirus Outcomes Registry (PRIORITY) Study
por: Flaherman, Valerie J, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
por: Pedersen, Ole Birger, et al.
Publicado: (2020)

Rapid Real-time Tracking of Nonpharmaceutical Interventions and Their Association With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity: The Coronavirus Disease 2019 (COVID-19) Pandemic Pulse Study
por: Clipman, Steven J, et al.
Publicado: (2020)

Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study
por: Miranda, Marisol, et al.
Publicado: (2022)

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March–May 2020
por: Lane, Morgan A, et al.
Publicado: (2021)

Severity of SARS-CoV-2 reinfection in vaccinated healthcare workers
por: Golshahi, Fatemeh, et al.
Publicado: (2023)

Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
por: Mourão Toreli, Ana Carolina, et al.
Publicado: (2022)

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
por: Hensley, Matthew K, et al.
Publicado: (2021)

Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
por: Pilarowski, Genay, et al.
Publicado: (2020)

Serological Markers of SARS-CoV-2 Reinfection
por: Siddiqui, Sameed M., et al.
Publicado: (2022)

Reinfection with SARS-CoV-2: An inconvenient truth?
por: Sonié, Pedro, et al.
Publicado: (2022)

Epidemiological assessment of SARS-CoV-2 reinfection
por: Almadhi, Marwa, et al.
Publicado: (2022)

Reinfection, recontamination and revaccination for SARS-CoV-2
por: Kullmann, Tamás, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ma4kpkfe2a93s5rglu8mmavg95